SCHEMBL5109170

SCHEMBL5109170

CC(C)(C)OC(=O)C(N)Cc1cc(F)c(C(=O)O)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.43
LTA4H P09960 1/20 0.36
DPP4 P27487 2/20 0.36
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPK14 Q16539 2/20 0.33
LMNA P02545 2/20 0.33
TTR P02766 2/20 0.33
ADORA3 P0DMS8 2/20 0.33
THRB P10828 2/20 0.33
PDE4D Q08499 2/20 0.33
HSD17B10 Q99714 2/20 0.33
NR3C1 P04150 1/20 0.33
CYP1A2 P05177 1/20 0.33
HTR1A P08908 1/20 0.33
CYP2C9 P11712 1/20 0.33
TBXA2R P21731 1/20 0.33
NTSR1 P30989 1/20 0.33
HTR2B P41595 1/20 0.33
APP P05067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5109997 0.89 SLC7A5 (0.40) SLC7A5LTA4HDPP4MEN1KMT2A
SCHEMBL5106293 0.81 SLC7A5 (0.39) SLC7A5LTA4HDPP4MAPK14APP
SCHEMBL21029611 0.80 SLC7A5 (0.45) SLC7A5LTA4HDPP4MAPK14ADORA3
SCHEMBL31000666 0.79 SLC7A5 (0.52) SLC7A5MEN1KMT2ALMNATTR
SCHEMBL18256468 0.78 SLC7A5 (0.44) SLC7A5LTA4HDPP4MAPK14ADORA3
SCHEMBL19088473 0.78 SLC7A5 (0.44) SLC7A5LTA4HDPP4MAPK14ADORA3
SCHEMBL29551946 0.78 SLC7A5 (0.44) SLC7A5LTA4HDPP4MAPK14ADORA3
SCHEMBL30191722 0.78 SLC7A5 (0.44) SLC7A5KMT2ALMNAADORA3HSD17B10
SCHEMBL6391083 0.78 APP (0.40) SLC7A5DPP4KMT2ALMNAAPP
SCHEMBL21029427 0.77 SLC7A5 (0.45) SLC7A5LTA4HLMNAADORA3HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329764-B2 Substitute benzothiophene compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2008-02-12 US disclosed
EP-1651629-A1 SUBSTITUTED BENZOTHIOPHENE COMPOUNDS AND USES THEREOF BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2006-05-03 EP disclosed
US-20050038104-A1 Substitute benzothiophene compounds BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-02-17 US disclosed
WO-2005012283-A1 SUBSTITUTED BENZOTHIOPHENE COMPOUNDS AND USES THEREOF BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2005-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038104-A1 Substitute benzothiophene compounds TST, SULT1E1, LTC4S SLC7A5 2920/4885LTA4H 95/4885DPP4 2330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.